Skip to main content
. 2017 Jul 10;8(37):62524–62536. doi: 10.18632/oncotarget.19122

Table 2. The assessment of the risk of bias in each Cohort study using the Newcastle–Ottawa scale.

Study Selection(0-4) Comparablility (0-2) Outcome(0-3) Total
REC SNEC AE DO SC AF AO FU AFU
Chen TF 1 1 1 1 0 0 1 1 1 7
Hiltermann TJ 1 1 1 1 0 0 1 1 1 7
Sher YP 1 1 1 1 0 0 1 1 1 7
Hofman V 1 1 1 1 0 0 1 1 0 6
Hou JM 1 1 1 1 0 0 1 0 1 6
Igawa S 1 1 1 1 0 0 1 0 1 6
Shi WJ 1 1 1 1 0 0 1 0 1 6
Yamashita Y 1 1 1 1 0 0 0 1 1 6
Yie SM 1 1 1 1 0 0 1 1 0 6
Yoon SO 1 1 1 1 0 0 1 1 0 6
Krebs MG 0 1 1 1 0 0 1 0 1 5
Naito T 1 1 1 1 0 0 1 0 0 5
Nieva J 1 1 1 1 0 0 0 0 1 5
Juan O 0 1 1 1 0 0 1 0 1 5
Bayarri-Lara C 1 1 1 1 0 0 0 0 1 5
Chen X 1 1 1 1 0 0 1 0 0 5
Hirose T 0 1 1 1 0 0 1 0 1 5
Ji JL 1 1 1 1 0 0 1 0 0 5
Peck K 1 1 1 1 0 0 1 0 0 5
Sheu CC 1 1 1 1 0 0 1 0 0 5
Wang B 1 1 1 1 0 0 1 0 0 5
Wu C 1 1 1 1 0 0 1 0 0 5
Feng YQ 1 1 1 1 0 0 1 0 0 5
Lin XM 1 1 1 1 0 0 1 0 0 5
Qian Z 1 1 1 1 0 0 1 0 0 5
Lou JT 1 1 1 1 0 0 0 0 0 4
Xu YH 0 1 1 1 0 0 1 0 0 4
Huang TH 1 1 1 1 0 0 0 0 0 4
Li J 0 1 1 1 0 0 1 0 0 4
Zhao SW 1 1 1 1 0 0 0 0 0 4